Developer docs
API playgroundTry for free, no card

Search company profiles

Harvest One Cannabis

Full company profile

uuid0005wdx

Namestring
Harvest One Cannabis
Legal namestring
Delivra Health Brands Inc.
Websiteurl
harvestone.com
Company typeenum
Public
Founded yearint
2017
Descriptiontext

Delivra Health Brands Inc. (formerly Harvest One Cannabis) is a Vancouver-based, publicly traded consumer health and wellness company (TSXV: DHB; OTCQB: DHBUF) operating a portfolio of three core brands: Dream Water® (sleep aids), LivRelief™ (natural topical pain creams built on a proprietary transdermal delivery system), and Infused Topicals (cannabis-infused topicals). The Infused Topicals line holds a regulatory first-mover position as the first topical product approved and sold in the Canadian medical cannabis market. The company was originally established as Harvest One Cannabis in 2017 (the corporate group traces back to 2008) and rebranded to Delivra Health Brands in 2021 to signal a deliberate strategic pivot from pure-play cannabis toward broader consumer health and wellness categories, including a non-cannabis sleep franchise. The LivRelief™ franchise is built on proprietary transdermal delivery technology acquired through the 2019 acquisition of Delivra Corp., which the company describes as the technical differentiator for its topical pain-relief SKUs. The Dream Water® franchise was added via the May 2018 acquisition of Dream Water USA and Dreamwater Products Canada.

The company makes money by selling branded consumer wellness products — sleep aids, natural topical pain creams, and cannabis-infused topicals — through international retail distribution (over 20 countries) and through a direct medical distribution channel in Canada for its cannabis-infused topical line. Its customer base is described as millions of end consumers across multiple product lines, with a horizontal segmentation approach targeting Health and Wellness Consumers suffering from chronic pain, anxiety, sleeplessness, reduced mobility, and low energy. Go-to-market relies on corporate-website digital presence, email/newsletter communications, and a network of distributors and wholesalers internationally; pricing is not publicly disclosed. Recent strategic activity includes the March 2026 US launch of Dream Water® Kids Sleep Gummies (a new demographic and geography) and the April 2026 licensing agreement with Peak Processing to manufacture and distribute LivRelief Infused™. The company reports quarterly results and maintains a standard public-company governance structure with an 11–50 employee base.

Short descriptiontext

Delivra Health Brands (formerly Harvest One Cannabis) is a Vancouver-based public consumer wellness company that sells Dream Water® sleep aids, LivRelief™ topical pain creams using a proprietary transdermal delivery system, and cannabis-infused topicals to end consumers in over 20 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVancouver, Canada
HQ citystring
Vancouver
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
sleep aid products, topical pain relief, cannabis topicals, transdermal delivery, consumer health wellness
Industry2 codes
1Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
CodeCRANAFAIPrimaryYes
2Cannabis Dispensary + Wellness/Apothecary Format (Supplements, Skincare, etc.)
CodeCRANAFAJPrimaryNo
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Consumer Health & Wellness Products
Social media profiles1 record
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Supply Chain, Marketing or Sales, Personnel, Technology or R&D
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Dream Water®
Description

Sleep aid product line including sleep gummies and sleep water products for the sleep market.

delivrahealthbrands.com
+2 more records
Core offering1 text field

Harvest One Cannabis, operating as Delivra Health Brands, is a publicly traded health and wellness company that develops, manufactures, and sells consumer products including the Dream Water® sleep aid line, LivRelief™ topical pain relief creams featuring a proprietary transdermal delivery system, and Infused Topicals (cannabis-infused topical products). The company sells its branded products through international retail distribution and the Canadian medical market across more than 20 countries.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Delivra Health Brands operates as a health and wellness company with a portfolio of three core consumer product brands: Dream Water® (sleep aid), LivRelief™ (topical pain relief cream with proprietary transdermal delivery system), and Infused Topicals (cannabis-infused topical products). The company serves customers in over 20 countries, offering alternative wellness solutions for chronic pain, anxiety, and sleeplessness. The product portfolio includes a recent expansion with Dream Water® Kids Sleep Gummies targeting the children's sleep market in the United States.

Product and service4 records
1Dream Water®
CategorySleep Aid Consumer Products
Description

Sleep aid product line positioned as an industry leader in the rapidly expanding sleep market. Includes sleep gummies and sleep water products designed to help consumers with sleeplessness issues. Acquired by Harvest One Cannabis on 2018-05-03.

2LivRelief™
CategoryTopical Pain Relief Products
Description

Natural topical pain relief cream featuring a proprietary transdermal delivery system that enables effective absorption of active ingredients through the skin. Targeted at consumers suffering from chronic pain.

3Infused Topicals
CategoryCannabis Topical Products
Description

Cannabis-infused topical products and the first topical product approved and sold in the Canadian medical cannabis market. Targeted at medical cannabis patients and adult consumers seeking cannabis-based topical solutions.

4Dream Water® Kids Sleep Gummies
CategoryChildren's Sleep Aid Products
Description

Children's sleep aid gummy product launched in the United States, extending the Dream Water® brand to a new demographic (children).

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-22
Description

Delivra Health Brands entered into a license agreement with Peak Processing to manufacture and distribute its topical brand LivRelief Infused™. This partnership expands production and distribution capabilities for the company's infused topical product line.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

U.S.-listed hemp-CBD wellness company selling topical creams, tinctures and gummies for pain, sleep and anxiety. Closely comparable to Delivra's combination of a proprietary hemp/CBD topical platform and broader wellness SKUs targeting similar consumer use cases.

TypeDirect peer
Description

CBD wellness brand with a topical pain cream line alongside tinctures and sleep products. Directly comparable to LivRelief on the topical pain relief axis and to Dream Water on the sleep/relaxation consumer positioning.

TypeDirect peer
Description

Globally distributed hemp-CBD wellness company with topical and ingestible products for pain, sleep and stress. Comparable in product mix, regulatory exposure to cannabis-adjacent ingredients, and multi-country distribution model.

TypeBroad incumbent
Description

Large Canadian-licensed cannabis producer with medical cannabis distribution across multiple countries. Comparable as a broader incumbent in the medical cannabis channel in which Delivra's Infused Topicals competes, though Tilray operates at much greater scale.

TypeBroad incumbent
Description

Major Canadian cannabis producer with medical and consumer cannabis products in multiple international markets. Comparable on the cannabis distribution and regulatory footprint side, though Canopy is far larger and more diversified into dried flower, oils and beverages.

TypeBroad incumbent
Description

Canadian-licensed cannabis producer with a strong medical cannabis platform and international distribution. Comparable to Delivra's medical-channel focus for its Infused Topicals line.

TypeBroad incumbent
Description

Canadian cannabis producer with medical and recreational products distributed domestically and internationally. Comparable on regulatory exposure and Canadian medical-channel distribution.

TypeBroad incumbent
Description

Canadian-licensed cannabis producer with global distribution including wellness-adjacent product formats. Comparable as a broad incumbent operating in the same Canadian medical cannabis regulatory environment as Delivra.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Harvest One Cannabis

Consumer Health & Wellness Productsharvestone.com

Delivra Health Brands (formerly Harvest One Cannabis) is a Vancouver-based public consumer wellness company that sells Dream Water® sleep aids, LivRelief™ topical pain creams using a proprietary transdermal delivery system, and cannabis-infused topicals to end consumers in over 20 countries.

What Harvest One Cannabis does

Delivra Health Brands Inc. (formerly Harvest One Cannabis) is a Vancouver-based, publicly traded consumer health and wellness company (TSXV: DHB; OTCQB: DHBUF) operating a portfolio of three core brands: Dream Water® (sleep aids), LivRelief™ (natural topical pain creams built on a proprietary transdermal delivery system), and Infused Topicals (cannabis-infused topicals). The Infused Topicals line holds a regulatory first-mover position as the first topical product approved and sold in the Canadian medical cannabis market. The company was originally established as Harvest One Cannabis in 2017 (the corporate group traces back to 2008) and rebranded to Delivra Health Brands in 2021 to signal a deliberate strategic pivot from pure-play cannabis toward broader consumer health and wellness categories, including a non-cannabis sleep franchise. The LivRelief™ franchise is built on proprietary transdermal delivery technology acquired through the 2019 acquisition of Delivra Corp., which the company describes as the technical differentiator for its topical pain-relief SKUs. The Dream Water® franchise was added via the May 2018 acquisition of Dream Water USA and Dreamwater Products Canada.

The company makes money by selling branded consumer wellness products — sleep aids, natural topical pain creams, and cannabis-infused topicals — through international retail distribution (over 20 countries) and through a direct medical distribution channel in Canada for its cannabis-infused topical line. Its customer base is described as millions of end consumers across multiple product lines, with a horizontal segmentation approach targeting Health and Wellness Consumers suffering from chronic pain, anxiety, sleeplessness, reduced mobility, and low energy. Go-to-market relies on corporate-website digital presence, email/newsletter communications, and a network of distributors and wholesalers internationally; pricing is not publicly disclosed. Recent strategic activity includes the March 2026 US launch of Dream Water® Kids Sleep Gummies (a new demographic and geography) and the April 2026 licensing agreement with Peak Processing to manufacture and distribute LivRelief Infused™. The company reports quarterly results and maintains a standard public-company governance structure with an 11–50 employee base.

Harvest One Cannabis firmographics

Firmographics
Name
Harvest One Cannabis
Legal name
Delivra Health Brands Inc.
Website
https://harvestone.com
Company type
Public
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Delivra Health Brands (formerly Harvest One Cannabis) is a Vancouver-based public consumer wellness company that sells Dream Water® sleep aids, LivRelief™ topical pain creams using a proprietary transdermal delivery system, and cannabis-infused topicals to end consumers in over 20 countries.
Ownership category
akta.pro rank

Harvest One Cannabis industry classification

Industry
Product category
Consumer Health & Wellness Products
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
akta.pro secondary industry
Cannabis Dispensary + Wellness/Apothecary Format (Supplements, Skincare, etc.) (CRANAFAJ)

Keywords

  • Sleep aid products
  • Topical pain relief
  • Cannabis topicals
  • Transdermal delivery
  • Consumer health wellness

Where Harvest One Cannabis is headquartered

Location

Headquarters

HQ city
Vancouver
HQ country
Canada
HQ region
North America

Markets served

Harvest One Cannabis business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Marketing or Sales, Personnel, Technology or R&D

Distribution channels2 records

Marketing channels2 records

Harvest One Cannabis product offering

Product offering

Core offering

Harvest One Cannabis, operating as Delivra Health Brands, is a publicly traded health and wellness company that develops, manufactures, and sells consumer products including the Dream Water® sleep aid line, LivRelief™ topical pain relief creams featuring a proprietary transdermal delivery system, and Infused Topicals (cannabis-infused topical products). The company sells its branded products through international retail distribution and the Canadian medical market across more than 20 countries.

Product overview

Delivra Health Brands operates as a health and wellness company with a portfolio of three core consumer product brands: Dream Water® (sleep aid), LivRelief™ (topical pain relief cream with proprietary transdermal delivery system), and Infused Topicals (cannabis-infused topical products). The company serves customers in over 20 countries, offering alternative wellness solutions for chronic pain, anxiety, and sleeplessness. The product portfolio includes a recent expansion with Dream Water® Kids Sleep Gummies targeting the children's sleep market in the United States.

Differentiator

Problem solved

Functional benefit

Brands

  • Dream Water®: Sleep aid product line including sleep gummies and sleep water products for the sleep market.
  • LivRelief™
  • Infused Topicals

Products and services

  • Dream Water® Sleep aid product line positioned as an industry leader in the rapidly expanding sleep market. Includes sleep gummies and sleep water products designed to help consumers with sleeplessness issues. Acquired by Harvest One Cannabis on 2018-05-03.
  • LivRelief™ Natural topical pain relief cream featuring a proprietary transdermal delivery system that enables effective absorption of active ingredients through the skin. Targeted at consumers suffering from chronic pain.
  • Infused Topicals Cannabis-infused topical products and the first topical product approved and sold in the Canadian medical cannabis market. Targeted at medical cannabis patients and adult consumers seeking cannabis-based topical solutions.
  • Dream Water® Kids Sleep Gummies Children's sleep aid gummy product launched in the United States, extending the Dream Water® brand to a new demographic (children).

Companies that use Harvest One Cannabis

Customer profile

Segments1 record

Ideal customer profiles2 records

Harvest One Cannabis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Harvest One Cannabis partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Peak ProcessingcoreChannel Partner/ Reseller/ Distributor · 22 April 2026Delivra Health Brands entered into a license agreement with Peak Processing to manufacture and distribute its topical brand LivRelief Infused™. This partnership expands production and distribution capabilities for the company's infused topical product line.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Harvest One Cannabis competitors and assessment

Company assessment

Direct peers

  • Charlotte's Web Holdings: U.S.-listed hemp-CBD wellness company selling topical creams, tinctures and gummies for pain, sleep and anxiety. Closely comparable to Delivra's combination of a proprietary hemp/CBD topical platform and broader wellness SKUs targeting similar consumer use cases.
  • cbdMD: CBD wellness brand with a topical pain cream line alongside tinctures and sleep products. Directly comparable to LivRelief on the topical pain relief axis and to Dream Water on the sleep/relaxation consumer positioning.
  • Elixinol Wellness: Globally distributed hemp-CBD wellness company with topical and ingestible products for pain, sleep and stress. Comparable in product mix, regulatory exposure to cannabis-adjacent ingredients, and multi-country distribution model.

Broad incumbents

  • Tilray Brands: Large Canadian-licensed cannabis producer with medical cannabis distribution across multiple countries. Comparable as a broader incumbent in the medical cannabis channel in which Delivra's Infused Topicals competes, though Tilray operates at much greater scale.
  • Canopy Growth Corporation: Major Canadian cannabis producer with medical and consumer cannabis products in multiple international markets. Comparable on the cannabis distribution and regulatory footprint side, though Canopy is far larger and more diversified into dried flower, oils and beverages.
  • Aurora Cannabis: Canadian-licensed cannabis producer with a strong medical cannabis platform and international distribution. Comparable to Delivra's medical-channel focus for its Infused Topicals line.
  • OrganiGram Holdings: Canadian cannabis producer with medical and recreational products distributed domestically and internationally. Comparable on regulatory exposure and Canadian medical-channel distribution.
  • Cronos Group: Canadian-licensed cannabis producer with global distribution including wellness-adjacent product formats. Comparable as a broad incumbent operating in the same Canadian medical cannabis regulatory environment as Delivra.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Harvest One Cannabis social profiles

Digital presence

Harvest One Cannabis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Harvest One Cannabis leadership team

Management profile

Number of profiles

Profiles4 records

Harvest One Cannabis funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Harvest One Cannabis M&A and investment

M&A and investment

M&A4 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Harvest One Cannabis

What does Harvest One Cannabis do?

Harvest One Cannabis, operating as Delivra Health Brands, is a publicly traded health and wellness company that develops, manufactures, and sells consumer products including the Dream Water® sleep aid line, LivRelief™ topical pain relief creams featuring a proprietary transdermal delivery system, and Infused Topicals (cannabis-infused topical products). The company sells its branded products through international retail distribution and the Canadian medical market across more than 20 countries.

Is Harvest One Cannabis a public or private company?

Harvest One Cannabis is a public company. It is classified as public and is currently operating.

When was Harvest One Cannabis founded?

Harvest One Cannabis was founded in 2017. It employs 11 to 50 people.

Where is Harvest One Cannabis based?

Harvest One Cannabis is headquartered in Vancouver, Canada, in the North America region.

Who are Harvest One Cannabis's main competitors?

Direct peers on record are Charlotte's Web Holdings, cbdMD and Elixinol Wellness. Broad incumbents are Tilray Brands, Canopy Growth Corporation, Aurora Cannabis, OrganiGram Holdings and Cronos Group.

Does Harvest One Cannabis have an API?

No public API is recorded for Harvest One Cannabis.

What industry is Harvest One Cannabis in?

Harvest One Cannabis's product category is Consumer Health & Wellness Products. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of CRANAFAJ, Cannabis Dispensary + Wellness/Apothecary Format (Supplements, Skincare, etc.). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireThe Valens Company Enters Agreement with Harvest One to Manufacture and Distribute Leading Cannabis-Infused Topical Brand LivRelief™The Valens Company Inc. signed a two-year agreement with Harvest One Cannabis Inc. to become the white label manufacturer and provincial sales partner for LivRelief, the number one selling cannabis-infused topical brand in Ontario, Canada's largest market with over 20% market share. The partnership will see Valens manufacture and distribute LivRelief's line of topical creams in three formats (CBD-only, 1:1 THC:CBD, and extra strength CBD) across Canadian provincial and private retailers, with first shipments expected at the beginning of fiscal Q4 2021. The agreement positions Valens as a clear leader in both the topicals and health and wellness verticals in Canada, adding LivRelief to its existing portfolio that already includes the number one selling bath product in Ontario.PR NewswireHarvest One Announces Leadership ChangesHarvest One Cannabis Inc.'s Board of Directors appointed Andy Bayfield, currently Chief Commercial Officer, as Interim CEO effective immediately, while also appointing Frank Holler as Executive Chairman. Concurrent with these appointments, Grant Froese resigned from the CEO position and the Board, though he will continue supporting the company as a consultant. The leadership changes occur as Harvest One continues its strategic review process, having already implemented cost-cutting initiatives and completed sales of non-core assets including Burb and the Lillooet property.PR NewswireHarvest One Provides Strategic Update and Announces Q2 2020 Financial ResultsHarvest One Cannabis Inc. reported significant financial deterioration for Q2 2020, with net revenue dropping 53% year-over-year to $1.77 million and operating losses tripling to $15.9 million for the quarter, impacted by industry-wide factors including product returns, pricing adjustments, and reduced provincial orders. The company announced a strategic refocus on brands and distribution while divesting non-core assets, including the sale of its 19.99% interest in Burb Cannabis Corp. for $1.5 million and a 398-acre site in Lillooet for $770,000, and implementing a 30% annualized reduction in SG&A expenses through workforce cuts and office consolidation. Looking ahead, the company expects Cannabis 2.0 product launches including LivRelief topical creams and Satipharm CBD capsules to drive future growth, with early Q3 sales volumes showing improvement from the prior quarter.PR NewswireHarvest One Announces Sale of Non-Core Interest in Burb and Lillooet Property for Total Proceeds of $2.3 millionHarvest One Cannabis Inc. has completed the sale of its 19.9% equity stake in Burb Cannabis Corp. back to Burb's founders for $1,512,600 cash, along with the forgiveness of a $250,000 shareholder loan, with the transaction closing on February 25, 2020. The company has also entered into an agreement to sell its 398-acre Lillooet Property in British Columbia for $770,000, scheduled to close on March 31, 2020, bringing total proceeds to approximately $2.3 million. Proceeds from both transactions are expected to support Harvest One's branding and distribution efforts related to Cannabis 2.0 products.PR NewswireHarvest One Announces Review of Strategic AlternativesHarvest One Cannabis Inc. announced on February 12, 2020, that its Board of Directors has initiated a strategic review process to evaluate available alternatives for the company, appointing Mackie Research Capital Corporation and AltaCorp Capital Inc. as exclusive financial advisors and establishing a special committee of independent directors to oversee the process. The company, which has re-focused on Cannabis 2.0 lifestyle and wellness products through subsidiaries including Satipharm, Dream Water Global, and Delivra, noted that its largest shareholder MMJ Group Holdings Limited advanced a $2.0 million bridge loan and expressed support for the review while characterizing the company as significantly undervalued. No definitive timeline has been established and no decisions regarding any strategic transaction have been reached.PR NewswireHarvest One Reports Fourth Quarter and Year End Financial Results for 2019Harvest One Cannabis Inc. reported Q4 and full-year fiscal 2019 financial results ending June 30, 2019, achieving net revenue of $3.0 million for Q4 and $11.5 million for the full year, representing 489% and 1,479% increases respectively over 2018, though the company reported a net loss of $13.6 million for Q4 and $27.9 million for the year. Post-quarter, Harvest One completed the acquisition of Delivra Corp. and its LivRelief brand, entered supply agreements with GenCanna Global USA and Stevens Green, received a cultivation license for Phase 1 of United Greeneries' Mission Road facility, and obtained an amendment to sell cannabis oil products. Management indicated fiscal 2020 will benefit from increased production capacity and new cannabis derivative products under recent Canadian legislation changes.PR NewswireHarvest One Announces Receipt of New Cultivation LicenceHarvest One Cannabis Inc., through its wholly-owned subsidiary United Greeneries Ltd., has received a cultivation license from Health Canada for Phase I of its new Mission Road facility in Duncan, British Columbia. The license enables immediate cannabis cultivation at the facility, which when fully completed will triple the company's existing production capacity in Duncan. The expanded production is expected to facilitate entry into additional provincial markets for Harvest One's adult-use brands, including Royal High and Captain's Choice.PR NewswireHarvest One Congratulates Deb Milimaka Miles for Winning a Woman of Inspiration AwardHarvest One Cannabis Inc. announced and congratulated Chief People Officer and CAO Deb Milimaka Miles for receiving a Woman of Inspiration Award in the SupportHER category, recognizing her mentorship work empowering women in leadership roles. The award was presented at a gala dinner held the previous evening. Women of Inspiration has nationally recognized over 300 women and awarded 40 Women of Inspiration Awards since its inception.PR NewswireCannabis Virtual Investor Conference Presentations Now Available for On-Demand ViewingThe article announces the availability of presentations from the September 12th Cannabis Industry Virtual Investor Conference for on-demand viewing at VirtualInvestorConferences.com. Several cannabis-related companies participated in the conference, including Vapen MJ Ventures, Akerna, MPX International, and others. The presentations will be accessible for 90 days and shareholders can download materials for two weeks.PR NewswireHarvest One Obtains Canadian Cannabis Oil LicenceHarvest One Cannabis Inc., through its wholly-owned subsidiary United Greeneries Ltd., obtained an amendment to its Health Canada licence on September 6, 2019, allowing the sale of cannabis oil products. The licence enables initial sales to provincial and private retailers in British Columbia, Ontario, Saskatchewan, and Manitoba, positioning the company to launch THC- and CBD-infused versions of its existing brands including Dream Water, LivRelief, Royal High, and Satipharm. The company is also developing vape and infused products through licensed third-party partners for launch when derivative regulations come into effect later in 2019.